What Is Tivicay Prescribed For? Uses and Side Effects

Tivicay (dolutegravir) is prescribed for the treatment of HIV-1 infection. It is FDA-approved for use in adults and children as young as 4 weeks old (weighing at least 3 kg), and it works by blocking a specific step in the virus’s ability to copy itself inside your cells. Tivicay is not a standalone treatment. It is always used alongside other HIV medications as part of a combination regimen.

Who Can Be Prescribed Tivicay

Tivicay covers a broad range of people living with HIV-1. It is approved for adults who have never been treated for HIV before, as well as adults who have taken other HIV medications in the past. For children, it is approved starting at 4 weeks of age and a minimum weight of about 6.6 pounds (3 kg), provided the child has not previously been on the same class of drug that Tivicay belongs to (an integrase inhibitor).

There is also a specific approval for adults whose virus is already well controlled. If you’ve been on a stable HIV regimen for at least six months and your viral load is undetectable (below 50 copies per milliliter), your provider may simplify your treatment by switching you to Tivicay paired with rilpivirine as a two-drug regimen. This option is limited to people with no history of treatment failure and no known drug resistance to either medication.

How Tivicay Works

HIV reproduces by inserting its own genetic material into the DNA of your immune cells. Tivicay blocks the enzyme responsible for that insertion, called integrase. Without this step, the virus cannot hijack your cells to make new copies of itself. This mechanism is why Tivicay belongs to a drug class called integrase inhibitors.

One of the reasons Tivicay became a cornerstone of HIV treatment is its high genetic barrier to resistance. That means the virus typically needs to accumulate multiple mutations before it can work around the drug, which is harder and takes longer compared to some older HIV medications. The World Health Organization has noted this high barrier as a key advantage, though emerging resistance has been documented in some populations over time.

Common Drug Combinations

Tivicay is almost always prescribed as part of a multi-drug regimen. The most common triple-therapy combinations pair it with two other antivirals, typically lamivudine/abacavir or emtricitabine/tenofovir. These “backbone” drugs attack HIV at different stages of its life cycle, making it much harder for the virus to develop resistance to the entire regimen at once.

For people already virologically suppressed, a simpler two-drug option exists: Tivicay combined with lamivudine. Both U.S. and European HIV treatment guidelines support this as a switch strategy, with the caveat that it should not be used in people with active hepatitis B infection or when prior resistance test results are unavailable. The appeal of two-drug therapy is fewer medications overall, which can reduce long-term side effects and simplify daily pill counts.

Standard Dosing for Adults

For most adults, the dose is 50 mg taken once daily. This applies whether you are starting HIV treatment for the first time or switching from another regimen. However, the dose doubles to 50 mg twice daily in two situations: when you are taking certain other medications that speed up how your body processes Tivicay (reducing its effectiveness at the standard dose), or when you have previously been on an integrase inhibitor and there is suspected or confirmed resistance to that drug class.

Use During Pregnancy

Tivicay is classified as a preferred HIV medication during pregnancy across all three trimesters, and it is also considered appropriate for people who are trying to conceive. Early data from Botswana initially raised concern about a possible link to neural tube defects in infants exposed during conception, but the most recent and larger analyses show the rate of neural tube defects in infants born to women taking Tivicay at conception is no longer statistically different from the rate seen with other HIV medications. No dose adjustment is needed during pregnancy, though drug levels in the blood do dip somewhat during the third trimester. Those lower levels still remain well above the threshold needed to keep the virus suppressed.

One practical note for pregnant individuals: Tivicay should be taken at least two hours apart from prenatal vitamins or any supplement containing iron or calcium, because these minerals interfere with absorption of the drug.

Pediatric Formulations

Children have access to two versions of Tivicay. Tivicay PD is a dispersible tablet designed for infants and young children starting at 4 weeks old and 3 kg. It can be dissolved in water for easier dosing. The standard film-coated Tivicay tablet is available for children and adolescents weighing at least 14 kg (about 31 pounds). Dosing in children is weight-based, so it is adjusted as the child grows.

Side Effects

Tivicay is generally well tolerated. In clinical trials of adults starting HIV treatment for the first time, the only side effects occurring at moderate-to-severe intensity in 2% or more of participants were insomnia (up to 3%) and headache (up to 2%). Milder sleep disturbances were somewhat more common, reported by up to 7% of participants in one major trial.

Weight gain and changes in body fat distribution have been observed more broadly with HIV treatment in general, including regimens that contain Tivicay. These changes can include increased fat around the midsection, the back of the neck, or the chest, sometimes accompanied by fat loss in the face or limbs. The prescribing information does not isolate a specific incidence rate for weight gain with Tivicay alone, but it is a recognized concern across integrase inhibitor-based regimens and something worth discussing with your provider if you notice significant changes.

Important Timing With Other Medications

Tivicay’s absorption is reduced by products containing certain minerals. Antacids, calcium supplements, iron supplements, and buffered medications can all interfere if taken at the same time. The standard guidance is to take Tivicay either two hours before or six hours after these products. This is especially relevant for people on prenatal vitamins, daily calcium, or over-the-counter heartburn remedies. Certain medications that affect liver enzymes can also reduce Tivicay’s effectiveness, which is why some people require the higher twice-daily dose.